A Globally Rising Burden of Sexually Transmitted Diseases (STDs)
Pharma News for CG Oncology, Amgen, Elevar, and GSK
CG Oncology Teams Up With Merck &...

FDA Gives Green Signal to First Measles Vaccine in Almost 50 Years GSK announced that the company's vaccine...

pharma-news-for-noxxon-nuvalent-stryker-exact-sciences
Noxxon’s NOX-A12 clinical trial; Exac...

Noxxon continues enrolment in a glioblastoma therapy trial Noxxon Pharma continues subject enrolment in the...

femtech-market
FemTech Market: With 100+ Startups in...

Gender disparity is not new to ears. To look at all the corners, women have been and are still affected&hel...

global-burden-of-sexually-transmitted-diseases-std
A Globally Rising Burden of Sexually Transmitted Diseases (STDs)

Caused by bacteria, viruses, and parasites, Sexually transmitted diseases (STDs) are a global health burden and it seems they are likely to maintain their status of being so in coming years also, ...


latest pharma news
AZ, Daiichi inks an oncology deal; Moderna begins Phase III trial of its COVID-19 vaccine; No goo...

AZ, Daiichi put their trust into TROP2-based drugs, inks an oncology deal to together develop and commercialize DS-1062 AstraZeneca has inked an oncology deal with Daiichi Sankyo to jointly de...


recent-pharma-news-and-update
Olema raises $54M; T3 Pharma bags $27M to advance bacterial cancer therapy program; Biofourmis an...

Olema Oncology raises USD 54 Million for breast cancer program Olema Oncology has raised USD 54 million to push its lead program into the clinic and boost its R&D efforts in other areas.&nb...


latest-pharma-news-and-updates
Orchard licenses gene therapy tech from GSK; Glympse raises $46M; FDA voted to recommend Terlipre...

Orchard licenses the gene therapy technology from GlaxoSmithKline  Orchard Therapeutics has permitted lentiviral stable cell line technology from GlaxoSmithKline for its use in hematopoiet...


Postpartum Depression Market | PPD Market
Spot the Signs and Fight Postpartum Depressions

The Postpartum Depression Market Size in the 7MM was estimated to be USD 138.75 Million in 2017 and is expected to grow further with rise in PPD prevalence and immense opportunities with only a si...


pharma-news
Lassen’s anti-IL-11 antibody; PTC’s COVID-19 trial; Lenzilumab’s result; Orca raises $192M

Lassen Therapeutics to create anti-IL-11 antibody for cancer and fibrosis Lassen Therapeutics is revealing USD 31 million from Frazier Healthcare Partners, Alta Venture and Longwood Fund and ha...


Rheumatoid Arthritis Whitepaper
Rheumatoid Arthritis...

Rheumatoid Arthritis (RA) is a chronic, inflammatory autoimmune disease that leads to progressive an.....

TLR 7 and 8 Agonist
Toll-like receptors (TLR)...

Toll-like receptors (TLR) 7 and 8 are functionally localized to endosomes and recognize specific RNA.....

Gene Therapies Whitepaper
Gene Therapies

Gene therapies are regarded as one of the potential revolution in the Pharmaceutical field and Healt.....